What are the MRI features of intracerebral hemorrhage from the hyperacute to chronic stages?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

MRI Features of Intracerebral Hemorrhage by Stage

The MRI appearance of intracerebral hemorrhage evolves through five distinct stages based on hemoglobin degradation products and their paramagnetic properties, with characteristic signal patterns on T1-weighted and T2-weighted sequences that allow accurate phase determination 1.

Understanding the Evolution

The MRI signal characteristics depend primarily on the chemical form of hemoglobin (oxyhemoglobin → deoxyhemoglobin → methemoglobin → hemosiderin/ferritin) and whether these products remain intracellular or extracellular 1. The paramagnetic properties create two key effects: dipole-dipole interaction (shortens T1) and magnetic susceptibility (shortens T2) 1.


Stage-by-Stage MRI Features

Hyperacute Stage (<24 hours)

  • T1-weighted: Isointense to hypointense (long T1)
  • T2-weighted: Hyperintense (long T2)
  • Key feature: Intracellular oxyhemoglobin
  • Pitfall: Invariably shows focal hypointensity within the hyperacute hematoma on DWI 2
  • Edema: Hyperintense rim surrounding hematoma on T2/FLAIR 2
  • ADC value: Reduced (mean ratio 0.73) 2

The hyperacute stage mimics edema or infarction on conventional sequences, making it potentially confusing. MRI with gradient-echo or susceptibility-weighted sequences can detect hyperacute ICH with 100% sensitivity 3.

Acute Stage (1-3 days)

  • T1-weighted: Isointense to hypointense (long T1)
  • T2-weighted: Markedly hypointense centrally (short T2)
  • Key feature: Intracellular deoxyhemoglobin
  • Mechanism: Magnetic susceptibility effect from paramagnetic deoxyhemoglobin 1
  • Edema: Hyperintense rim on T2/proton density images 4
  • ADC value: Reduced (mean ratio 0.72) 2
  • DWI: Hypointense 2

At 3.0T, acute ICH shows significantly increased hypointensity on T2-weighted images compared to 1.5T, though both field strengths are equivalent for determining hemorrhage age 5.

Early Subacute Stage (3-7 days)

  • T1-weighted: Hyperintense peripherally, progressing centrally (short T1)
  • T2-weighted: Hypointense centrally with marked hypointense rim peripherally (short T2)
  • Key feature: Intracellular methemoglobin (starts at periphery, moves inward)
  • Mechanism: Paramagnetic dipole-dipole interaction shortens T1; magnetic susceptibility from intact red cells shortens T2 1
  • Edema: May persist as hyperintense rim 4
  • ADC value: Reduced (mean ratio 0.70) 2
  • DWI: Hypointense 2

The characteristic "bright on T1, dark on T2" pattern begins at the periphery where oxygenation is highest and progresses centrally over days 1.

Late Subacute Stage (7 days - several weeks)

  • T1-weighted: Markedly hyperintense throughout (short T1)
  • T2-weighted: Markedly hyperintense throughout (long T2)
  • Key feature: Extracellular methemoglobin (red cell lysis has occurred)
  • Mechanism: Methemoglobin remains paramagnetic (shortens T1), but loss of magnetic susceptibility effect allows T2 to lengthen 1
  • Hemosiderin rim: Marked hypointensity on T2 at periphery begins to appear 4
  • ADC value: Reduced (mean ratio 0.72) 2
  • DWI: Hyperintense 2

This is the "bright on everything" stage, though the developing hemosiderin rim creates a dark peripheral ring on T2-weighted images 1.

Chronic Stage (>weeks to months)

  • T1-weighted: Hyperintense to isointense centrally
  • T2-weighted: Variable central signal with marked hypointense rim (short T2)
  • Key feature: Hemosiderin deposition in macrophages at periphery
  • Mechanism: Magnetic susceptibility from hemosiderin creates profound T2 shortening 1
  • Edema: Resolved 4
  • ADC value: Markedly increased (mean ratio 2.56) 2
  • DWI: Hypointense 2

The hemosiderin rim persists indefinitely and serves as a permanent marker of prior hemorrhage 1. This is enhanced on gradient-echo and susceptibility-weighted sequences and reduced with fast spin-echo techniques 1.


Clinical Implications

MRI is more accurate than CT for detecting chronic ICH 3, making it superior for identifying prior hemorrhages when evaluating for conditions like cerebral amyloid angiopathy or hypertensive vasculopathy.

Important Caveats:

  • Field strength matters: 3.0T shows increased hypointensity in acute/early subacute stages on T2-weighted images but may occasionally cause acute ICH to be misinterpreted as early subacute 5
  • Sequence selection: Gradient-echo sequences enhance susceptibility effects; fast spin-echo reduces them 1
  • Blood-brain barrier integrity: Determines whether hemosiderin consistently accumulates in subacute/chronic stages 4

Recent diagnostic support software using multi-sequence MRI with color-coded hemorrhage maps has achieved "almost perfect agreement" (κ = 0.85) for phase estimation compared to "slight agreement" (κ = 0.06) with conventional visual evaluation 6, suggesting that systematic approaches to signal intensity analysis significantly improve diagnostic accuracy.

Related Questions

What is the recommended acute management for a pediatric intracerebral hemorrhage?
In patients with large lobar intracerebral hemorrhage (>30 mL) with midline shift ≥5 mm and coma (Glasgow Coma Scale < 8), does combined hematoma evacuation and decompressive craniectomy improve functional outcomes compared with evacuation alone or craniectomy alone?
In a 52-year-old intubated patient with intracerebral hemorrhage and a Glasgow Coma Scale of Eye 1, Verbal (intubated) and Motor 2, what does the presence of fixed, widely dilated pupils indicate?
Should HLA (human leukocyte antigen) testing be performed in a patient with intracerebral hemorrhage (ICH)?
What is the recommended management for an untreated intracerebral hemorrhage?
What is the recommended cytomegalovirus (CMV) prophylaxis regimen for solid-organ and hematopoietic stem-cell transplant recipients?
How should a patient with dural metastases and meningitis be treated?
Is the current treatment plan of methylphenidate extended‑release 30 mg each morning, methylphenidate 5 mg at noon, and clonidine 0.1 mg at bedtime appropriate for a child who continues to show defiance, verbal aggression, poor emotional regulation, impulsivity, and inattention despite long‑term stimulant therapy?
What are the differential diagnoses for cataract (lens opacity) in a patient presenting with visual decline?
What is the appropriate antibiotic regimen for an adult with a penicillin (amoxicillin) allergy presenting with a bacterial upper respiratory infection?
What is the safest sleep medication for an elderly patient (≥65 years) without severe hepatic impairment, uncontrolled depression, untreated obstructive sleep apnea, and not taking interacting drugs?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.